Cargando…
Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population
Intensive research is carried out to develop a disease-modifying drug for Alzheimer’s disease (AD). The development of drug candidates that reduce Aß or tau in the brain seems particularly promising. However, these drugs target people at risk for AD, who must be identified before they have any, or o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394767/ https://www.ncbi.nlm.nih.gov/pubmed/34117127 http://dx.doi.org/10.1136/medethics-2021-107304 |